Session 1: Novel Clinical Trial Updates
29th Annual PCF Scientific Retreat: October 27, 2022 | 1:05 PM – 2:25 PM
Moderator: Jake Vinson, MHA
The Prostate Cancer Clinical Trials Consortium
Targeting a Tumor-Specific CD46 Epitope in Metastatic Castration Resistant Prostate Cancer
Rahul Aggarwal, MD
University of California, San Francisco
Targeting Myeloid Chemotaxis via CXCR2 Blockade as a Therapeutic Strategy in Advanced Prostate Cancer
Christina Guo, MD
Institute for Cancer Research; Royal Marsden Hospital, UK
Biomarker Results from Targeting TROP2 with Sacituzumab Govitecan in mCRPC
Joshua Lang, MD
University of Wisconsin
TRITON3: A Phase 3 Study of Rucaparib vs. Physician’s Choice of Therapy in mCRPC associated with HRD
Alan Bryce, MD
Mayo Clinic